Clinical Trials Logo

Hypertrophy clinical trials

View clinical trials related to Hypertrophy.

Filter by:

NCT ID: NCT02873182 Not yet recruiting - Spinal Stenosis Clinical Trials

Protection of Autonomic Nervous System During Lower Spine Surgical Procedures: A Safety and Feasibility Study

Start date: August 2016
Phase: N/A
Study type: Interventional

A safety and feasibility study of free-run and stimulated corporal electromyography (EMG) to assess autonomic neural function during spinal and/or pelvic surgery in women and men.

NCT ID: NCT02862600 Recruiting - Clinical trials for Cardiomyopathy, Hypertrophic

Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure

Start date: August 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effect of perhexiline on exercise performance (efficacy) and safety in patients with hypertrophic cardiomyopathy and moderate-to-severe heart failure following dosing for 16 weeks.

NCT ID: NCT02849522 Active, not recruiting - Clinical trials for Transurethral Resection of the Prostate (TURP)

ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE).

UKROPE
Start date: April 2014
Phase: N/A
Study type: Observational [Patient Registry]

This is a study protocol for the UK ROPE Register for Lower Urinary Tract Symptoms (LUTS). This register enables us to collect data on the treatment of LUTS using prostate artery embolisation (PAE), and other surgical methods to answer the following questions posed by NICE in 2013: - Is PAE a safe and effective treatment option for LUTS caused by prostate enlargement? - How does PAE compare with conventional surgical treatments? This will primarily be a surgical procedure called TURP (see below). - Which patients would most benefit from PAE over the other treatment options? This is a pilot study, and the final register will contain data from roughly 100 patients for PAE and 100 patients for the other surgical interventions, allowing us to answer NICE's research questions, update NICE guidance documentation, and do further research with more patients if necessary. Our hypothesis is: • PAE produces significant improvements in the IPSS score 12 months post-procedure

NCT ID: NCT02842242 Completed - Clinical trials for Cardiomyopathy, Hypertrophic Obstructive

A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

PIONEER-HCM
Start date: August 2016
Phase: Phase 2
Study type: Interventional

The purpose of this phase 2 open-label pilot study is to evaluate the efficacy, pharmacokinetics (PK), pharmacodynamics (PD), safety, and tolerability of MYK-461 in subjects with symptomatic HCM and LVOT obstruction aged 18-70 years.

NCT ID: NCT02818647 Recruiting - Tonsillectomy Clinical Trials

Comparison of Cold Dissection Technique and Needle Monopolar Electrocautery Tonsillectomy

TONSIL
Start date: June 2016
Phase: N/A
Study type: Interventional

Patients 13-years-or older who undergo tonsillectomy operation (without another additional surgery) will be enrolled in the study. Randomly, one side is going to be operated with conventional cold-knife technique and hemostasis will be maintained with bipolar diathermy (25-30w). Contralateral tonsil is going to be operated with needle-tip monopolar electrocautery (10-12w) at Blend 1 mode and hemostasis will also be maintained with needle-tip monopolar cautery. Postoperative tonsillar fossa healing and pain is going to be evaluated for both sides separately with Visual Analogue Scale. All operations are going to be performed by a single surgeon and all evaluations are going to be carried out by another surgeon in a totally blinded fashion to avoid possible bias.

NCT ID: NCT02806479 Completed - Clinical trials for Coronary Artery Disease

Hypertrophic Cardiomyopathy Pilot Study

Start date: September 2016
Phase:
Study type: Observational

This study evaluates mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy, in comparison to patients with well-understood arrhythmogenic substrate (ischemic cardiomyopathy), as well as to individuals free from arrhythmogenic substrate

NCT ID: NCT02804269 Recruiting - Healthy Clinical Trials

Molecular and Imaging Studies of Cardiovascular Health and Disease

Biobank
Start date: July 2013
Phase: N/A
Study type: Observational

Biobank is a program which collects biological samples, health information and imaging data from consented patients and stored them at the core facility. These information would be used to study the molecular, imaging and outcome studies of cardiovascular health and disease.

NCT ID: NCT02783261 Active, not recruiting - Clinical trials for Hepatocellular Carcinoma

Prospective Post Y90 Liver Hypertrophy

Start date: June 2014
Phase: N/A
Study type: Observational

Patients undergoing Y90 radioembolization to will be followed prospectively with CT volumetry to determine post-Y90 rate of liver hypertrophy.

NCT ID: NCT02770053 Completed - Pain Postoperative Clinical Trials

Foraminal Enlargement and Postoperative Pain.

Start date: January 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether enlarging the apical foramen causes postoperative pain in teeth with necrotic pulp and apical periodontitis.

NCT ID: NCT02748434 Active, not recruiting - Diabetes Mellitus Clinical Trials

Glucose Variability in Subclinical Hypertrophy

Start date: October 2016
Phase: N/A
Study type: Interventional

Evaluation of insulin absorption at sites affected by clinically apparent lipohypertrophy through short-term continuous glucose monitoring has shown inconsistent results and it is yet unknown how or if subclinical lipohypertrophy affects absorption. In this study investigators propose to enroll at least 20 people who participated in phase 1 and who were determined to have subclinical lipohypertrophy to examine the correlation between glycemic control and amount of insulin injected in subclinical hypertrophic areas using capillary blood glucose and continuous glucose monitoring.